Legal Representation
Attorney
Frances M. Jagla
USPTO Deadlines
Next Deadline
103 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
October 24, 2025
Extension Available
Until October 24, 2024
Application History
29 eventsDate | Code | Type | Description |
---|---|---|---|
Apr 16, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Apr 15, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED |
Apr 15, 2025 | EXT3 | S | SOU EXTENSION 3 FILED |
Apr 15, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Oct 11, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED |
Oct 11, 2024 | EXT2 | S | SOU EXTENSION 2 FILED |
Oct 11, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Oct 11, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Mar 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Mar 12, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED |
Mar 12, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Mar 12, 2024 | EXT1 | S | SOU EXTENSION 1 FILED |
Oct 24, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Aug 29, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Aug 29, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
Aug 9, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jul 20, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jul 18, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jul 17, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jul 17, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jun 26, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jun 26, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED |
Jun 26, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jun 25, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
Jan 5, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Jan 5, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Jan 5, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Dec 22, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Dec 2, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders
Class 042
Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders
Class 044
Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders
Classification
International Classes
005
042
044
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO